FDA Approves Oral Duvyzat for Duchenne Muscular Dystrophy

MONDAY, March 25, 2024 -- The U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.Duvyzat is a histone deacetylase...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news